Opioid Use Disorder Diagnoses Surge 33% Among Commercially Insured Patients

  • Commercially insured patients with opioid use disorder diagnoses rose 32.7% from 2022 to 2025, per FAIR Health's Opioid Tracker.
  • Tennessee had the highest rate of diagnoses in 2025, with 1,551 patients per 100,000, followed by West Virginia and Mississippi.
  • Alcohol/substance abuse services accounted for 39% of all claim lines with an opioid use disorder diagnosis in 2025.
  • Nurse practitioners saw the fastest growth in involvement, with a 67% increase in claim lines from 2022 to 2025.

The sharp rise in opioid use disorder diagnoses underscores the ongoing public health crisis, with implications for insurers, providers, and policymakers. FAIR Health's data highlights the growing burden on the healthcare system, particularly in states with higher prevalence rates. The shift toward nurse practitioners and psychiatric nurses in treatment delivery reflects broader trends in healthcare workforce utilization.

Regional Disparities
How the significant variations in diagnosis rates across states will impact targeted healthcare interventions and policy responses.
Treatment Modalities
Whether the dominance of medication-assisted treatments like methadone will persist or shift toward alternative therapies.
Provider Dynamics
The pace at which nurse practitioners and psychiatric nurses expand their roles in opioid use disorder treatment.